Clinical Trial Update: Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update describing a Phase 0 study with expansion evaluating quisinostat plus radiotherapy in newly diagnosed and recurrent Grade 4 IDH-wildtype g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Idh-wildtype

Drugs mentioned

• Quisinostat (quisinostat)

Snippet

Sponsor: Nader Sanai | Conditions: Glioblastoma WHO Grade IV | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING